Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 107 (6) , 1039-1045
- https://doi.org/10.1067/mai.2001.115631
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Human late asthmatic reactionsClinical and Experimental Allergy, 1997
- Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts.Journal of Clinical Investigation, 1997
- Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchusEuropean Respiratory Journal, 1997
- Mast‐cell—leukocyte cytokine cascades in allergic inflammationAllergy, 1995
- Granulocyte Recruitment by Human Mast Cell TryptaseInternational Archives of Allergy and Immunology, 1995
- The effect of H1-receptor blockade on the development of early- and late-phase bronchoconstriction and increased bronchial responsiveness in allergen-induced asthmaJournal of Allergy and Clinical Immunology, 1993
- Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airwayJournal of Allergy and Clinical Immunology, 1991
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs.Journal of Clinical Investigation, 1989
- Antigen and methacholine challenge in children with asthmaJournal of Allergy and Clinical Immunology, 1979